June 13, 2025

Obicetrapib May Offer LDL Benefit

In a randomized trial of more than 2,500 patients at high cardiovascular risk, obicetrapib significantly reduced low-density lipoprotein cholesterol levels when added to existing lipid-lowering therapy.

Conexiant

June 13, 2025

Obicetrapib-Ezetimibe Combo Cuts LDL Nearly 50%

A phase 3 trial of an oral fixed-dose combination of obicetrapib and ezetimibe showed a nearly 50% reduction in LDL cholesterol levels in patients at high risk for heart disease, without added safety concerns.

Conexiant

June 13, 2025

Lifestyle Interventions Recommended First-Line in Diabetes

A new guideline recommends using lifestyle interventions as first-line treatment to prevent, manage, and potentially reverse type 2 diabetes and prediabetes, supported by extensive clinical evidence.

Conexiant

June 12, 2025

Vegetarian Diet Linked to Lower Cancer Incidence

A large North American cohort study found that vegetarian diets were associated with lower risks of several site-specific cancers, including colorectal, stomach, breast, prostate, and lymphoproliferative cancers.

Conexiant

June 11, 2025

Simvastatin Lowers Cholesterol—but Does Not Improve Depression Symptoms

A randomized trial of 160 adults with depression and obesity found no improvement in mood symptoms from adding simvastatin to escitalopram, though the statin significantly lowered cholesterol and inflammation levels.

Conexiant

June 04, 2025

Medical Oddities: Legumes Over Lipids?

From ticklish brains to bean-powered cholesterol drops, here’s what made the medical rounds weirdly wonderful this week.

Conexiant

June 04, 2025

Decoding the Exposome

ThermoFisher’s Susan Bird shares how tools such as mass spectrometry and AI are empowering the growing field of exposomics

The Analytical Scientist

June 04, 2025

Middle-Age Belly Fat: How Aging Stem Cells Tip the Scales

New research uncovers why fat cells multiply in the abdomen as we age–and points to possible ways to prevent it.

Conexiant

June 04, 2025

Oat Fiber Intake Tied to PFAS Reduction

A Canadian study found widespread PFAS exposure in adult men and observed that a four-week oat fiber intervention modestly reduced some long-chain PFAS levels in blood, with liver enzyme elevations linked to certain PFAS types.

Conexiant